Counteraction of estradiol-induced activation of tissue-type plasminogen activator in a human breast cancer cell line by an anti-estrogen, LY117018

This publication has 19 references indexed in Scilit:

• Induction of manganese superoxide dismutase by tumor necrosis factor in human breast cancer MCF-7 cell line and its TNF-resistant variant
  Biochemical and Biophysical Research Communications, 1989
• Vincristine‐resistant Human Cancer KB Cell Line and Increased Expression of Multidrug‐resistance Gene
  Japanese Journal of Cancer Research, 1988
• Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells
  Nucleic Acids Research, 1988
• Estrogen Inhibits the Growth of MCF‐7 Cell Variants Resistant to Transforming Growth Factor‐beta
  Japanese Journal of Cancer Research, 1988
• The pharmacology and clinical uses of tamoxifen
  Pharmacology & Therapeutics, 1984
• Inhibition of the Uterotropic Activity of Estrogens and Antiestrogens by the Short Acting Antiestrogen LY117018*
  Endocrinology, 1983
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
  Analytical Biochemistry, 1983
• EVIDENCE FOR BIOLOGICAL ACTION OF THE ANTIESTROGENS LY117018 AND TAMOXIFEN BY DIFFERENT MECHANISMS
  Endocrinology, 1981
• Induction of plasminogen activator by estrogen in a human breast cancer cell line (MCF-7)
  Biochemical and Biophysical Research Communications, 1979
• Estrogen Control of Progesterone Receptor in Human Breast Cancer: Role of Estradiol and Antiestrogen*
  Endocrinology, 1978